2021 年 38 巻 4 号 p. 661-665
The effect of immune checkpoint inhibitors has become clear, and its indication is expanding. Contrary to its effects, immune related adverse events (irAE) have become a problem. Neurologic irAE are relatively rare, yet potentially fatal. Neurologists should make appropriate diagnoses and treatments.